Antoun Toubaji Selected Research

Antoun Toubaji Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 08/2007
7	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 05/2008
4	Disease Progression 01/2022 - 03/2009
3	Adenocarcinoma 10/2015 - 03/2009
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2022
2	Acinar Cell Carcinoma 10/2015 - 06/2011
2	Kidney Neoplasms (Kidney Cancer) 05/2014 - 08/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2014 - 01/2010
2	Breast Neoplasms (Breast Cancer) 02/2012 - 08/2008
2	Prostatic Intraepithelial Neoplasia 08/2010 - 05/2008
1	Urachal adenocarcinoma 01/2022
1	Margins of Excision 11/2014
1	Leiomyomatosis 05/2014
1	Leiomyoma (Uterine Fibroids) 05/2014
1	Small Cell Carcinoma 06/2011
1	Medullary Carcinoma 08/2009
1	Seminoma 11/2008
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2008
1	Colorectal Neoplasms (Colorectal Cancer) 09/2008
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2008
1	Carcinogenesis 05/2008
1	Inflammation (Inflammations) 05/2008

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2015 - 08/2008
2	Biological ProductsIBA 01/2019 - 03/2009
2	Biomarkers (Surrogate Marker)IBA 11/2012 - 04/2010
2	AndrogensIBA 02/2012 - 08/2010
2	Androgen Receptors (Androgen Receptor)IBA 02/2012 - 08/2010
2	DNA (Deoxyribonucleic Acid)IBA 08/2010 - 11/2008
2	Peptides (Polypeptides)IBA 01/2010 - 09/2008
2	Protein Subunit VaccinesIBA 09/2008 - 08/2007
2	VaccinesIBA 09/2008 - 08/2007
1	cabozantinibIBA 01/2022
1	cyclopropapyrroloindoleIBA 01/2022
1	NivolumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	LipidsIBA 01/2019
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2014
1	Naphazoline (All Clear)FDA LinkGeneric 05/2014
1	Fumarate Hydratase (Fumarase)IBA 05/2014
1	FumaratesIBA 05/2014
1	SteroidsIBA 02/2012
1	Complementary DNA (cDNA)IBA 02/2012
1	Hormones (Hormone)IBA 02/2012
1	5-hydroxymethylcytosineIBA 08/2011
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2011
1	SynaptophysinIBA 01/2011
1	Histone Deacetylase InhibitorsIBA 01/2011
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2011
1	Chromogranin AIBA 01/2011
1	Protein Isoforms (Isoforms)IBA 08/2010
1	Serine Proteases (Serine Protease)IBA 08/2010
1	Cysteine-Rich Protein 61IBA 04/2010
1	IntegrinsIBA 04/2010
1	Monatide (IMS 3015)IBA 01/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2010
1	Cancer VaccinesIBA 01/2010
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 08/2009
1	DeoxycytidineIBA 11/2008
1	Messenger RNA (mRNA)IBA 08/2008
1	COOH-terminal signal transamidaseIBA 08/2008
1	Polyamine OxidaseIBA 05/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2008
1	EnzymesIBA 05/2008
1	PolyaminesIBA 05/2008
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2007
1	Therapeutic UsesIBA 08/2007
1	Interleukin-2 (IL2)IBA 08/2007

Therapy/Procedure

8	Therapeutics 01/2022 - 03/2009
5	Prostatectomy (Retropubic Prostatectomy) 11/2014 - 03/2009
1	Neoadjuvant Therapy 01/2022
1	Immunotherapy 09/2008